General Info
Location: Two Docklands Central, Level 4
Country: Ireland
Industries: Specialty Pharma, Biopharmaceuticals, Medical Devices, Diagnostics
Investment Regions: EU, NA
Investment Stages: seed
Website: http://www.fh-partners.com/
angel-group
EU, NA
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Fountain Healthcare Partners has a press release showing an investment in XyloCor Therapeutics dated January 7, 2025. From the reference date, that investment occurred between 6 and 3 months ago (approximately 10 months prior to November 1, 2025 would be incorrect – recalc: January 7, 2025 to November 1, 2025 is about 298 days, which is more than 6 months? Wait ensure reasoning aligns). Correction: January 7, 2025 to November 1, 2025 is ~298 days (~9.8 months) which falls between 12 and 6 months; therefore tag should be low-active.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
Ena …
Partner
Justin …
Partner and CFO
Manus …
Managing Partner and Co-Founder
Tania …
Associate
Aidan …
Managing Partner and Co-Founder
Warm Intros from Portfolio Companies
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Fountain Healthcare Partners

Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI
